» Articles » PMID: 38883982

Harnessing the Power of Artificial Intelligence in Predicting All-cause Mortality in Transcatheter Aortic Valve Replacement: a Systematic Review and Meta-analysis

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: In recent years, the use of artificial intelligence (AI) models to generate individualised risk assessments and predict patient outcomes post-Transcatheter Aortic Valve Implantation (TAVI) has been a topic of increasing relevance in literature. This study aims to evaluate the predictive accuracy of AI algorithms in forecasting post-TAVI mortality as compared to traditional risk scores.

Methods: Following the Preferred Reporting Items for Systematic Reviews and Meta-analyses for Systematic Reviews (PRISMA) standard, a systematic review was carried out. We searched four databases in total-PubMed, Medline, Embase, and Cochrane-from 19 June 2023-24 June, 2023.

Results: From 2,239 identified records, 1,504 duplicates were removed, 735 manuscripts were screened, and 10 studies were included in our review. Our pooled analysis of 5 studies and 9,398 patients revealed a significantly higher mean area under curve (AUC) associated with AI mortality predictions than traditional score predictions (MD: -0.16, CI: -0.22 to -0.10, < 0.00001). Subgroup analyses of 30-day mortality (MD: -0.08, CI: -0.13 to -0.03,  = 0.001) and 1-year mortality (MD: -0.18, CI: -0.27 to -0.10, < 0.0001) also showed significantly higher mean AUC with AI predictions than traditional score predictions. Pooled mean AUC of all 10 studies and 22,933 patients was 0.79 [0.73, 0.85].

Conclusion: AI models have a higher predictive accuracy as compared to traditional risk scores in predicting post-TAVI mortality. Overall, this review demonstrates the potential of AI in achieving personalised risk assessment in TAVI patients.

Registration And Protocol: This systematic review and meta-analysis was registered under the International Prospective Register of Systematic Reviews (PROSPERO), under the registration name "All-Cause Mortality in Transcatheter Aortic Valve Replacement Assessed by Artificial Intelligence" and registration number CRD42023437705. A review protocol was not prepared. There were no amendments to the information provided at registration.

Systematic Review Registration: https://www.crd.york.ac.uk/, PROSPERO (CRD42023437705).

Citing Articles

Machine-learning versus traditional methods for prediction of all-cause mortality after transcatheter aortic valve implantation: a systematic review and meta-analysis.

Zaka A, Mustafiz C, Mutahar D, Sinhal S, Gorcilov J, Muston B Open Heart. 2025; 12(1).

PMID: 39842939 PMC: 11784135. DOI: 10.1136/openhrt-2024-002779.


Identifying the Severity of Heart Valve Stenosis and Regurgitation Among a Diverse Population Within an Integrated Health Care System: Natural Language Processing Approach.

Xie F, Lee M, Allahwerdy S, Getahun D, Wessler B, Chen W JMIR Cardio. 2024; 8:e60503.

PMID: 39348175 PMC: 11474122. DOI: 10.2196/60503.

References
1.
Mamprin M, Lopes R, Zelis J, Tonino P, van Mourik M, Vis M . Machine Learning for Predicting Mortality in Transcatheter Aortic Valve Implantation: An Inter-Center Cross Validation Study. J Cardiovasc Dev Dis. 2021; 8(6). PMC: 8227005. DOI: 10.3390/jcdd8060065. View

2.
Lopes R, Mamprin M, Zelis J, Tonino P, van Mourik M, Vis M . Local and Distributed Machine Learning for Inter-hospital Data Utilization: An Application for TAVI Outcome Prediction. Front Cardiovasc Med. 2021; 8:787246. PMC: 8632813. DOI: 10.3389/fcvm.2021.787246. View

3.
Agasthi P, Ashraf H, Pujari S, Girardo M, Tseng A, Mookadam F . Artificial Intelligence Trumps TAVI-SCORE and CoreValve Score in Predicting 1-Year Mortality Post-Transcatheter Aortic Valve Replacement. Cardiovasc Revasc Med. 2020; 24:33-41. DOI: 10.1016/j.carrev.2020.08.010. View

4.
Nistal-Nuno B . Artificial intelligence forecasting mortality at an intensive care unit and comparison to a logistic regression system. Einstein (Sao Paulo). 2021; 19:eAO6283. PMC: 8483638. DOI: 10.31744/einstein_journal/2021AO6283. View

5.
Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71. PMC: 8005924. DOI: 10.1136/bmj.n71. View